Pharmaceutical Executive Daily: FDA Approves Three New Therapies
From Pharmaceutical Executive · · 3 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, and Ossium Health’s Kevin Caldwell joins The Ron Lanton Report on rebuilding bone marrow transplants around deceased-donor marrow.